Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$3.29 - $5.21 $135,877 - $215,173
-41,300 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$4.12 - $9.09 $90,228 - $199,071
21,900 Added 112.89%
41,300 $201,000
Q1 2020

May 12, 2020

SELL
$1.54 - $6.75 $156,310 - $685,125
-101,500 Reduced 83.95%
19,400 $42,000
Q3 2019

Oct 31, 2019

BUY
$3.04 - $4.91 $20,064 - $32,406
6,600 Added 5.77%
120,900 $384,000
Q1 2019

May 03, 2019

BUY
$5.74 - $8.05 $656,082 - $920,115
114,300 New
114,300 $790,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $161M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.